Skip to main content
ENS logo

ENS · EnerSys

Track ENS — free
$140.44 -2.56 (-1.79%)
Market Cap
$5.09B
Shares
35.59M
Volume · Nov 13 520.6K Avg daily vol (3M) 576.62K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$143.00 Open$146.41 Day$140.77–148.30 52W close$132.95–243.34 Avg vol 30d602K Short int2.5M · 7.2% of shares · 5.3d Short vol71% Last earningsNov 12, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 12

Up next

Feb 4, 2027 Est · unconfirmed · in 11 wks

Latest documents

2026
Nov 13
Tender offer SC TO-T/A
Ultralife offer amendment retains $16.00 expiration December 3, 2026

EnerSys amended its tender offer statement for Ultralife, offering $16.00 per share in cash. The offer expires at 5:00 p.m., New York City time, on December 3, 2026, unless extended or earlier terminated under the Merger Agreement.

Read from the first part of this long document
2 source passages
This Amendment No. 1 to the Tender Offer Statement on Schedule TO (this “Amendment”) amends and supplements the Tender Offer Statement on Schedule TO filed with the U.S. Securities and Exchange Commission on October 28, 2026 (as it may be further amended and supplemented from time to time, the “Schedule TO”) and relates to the tender offer by EnerSys Mergersub Inc., a Delaware corporation (“Merger Sub”) and a wholly owned subsidiary of EnerSys, a Delaware corporation (“EnerSys”) for any and all of the outstanding shares of common stock, par value $0.10 per share (the “Shares”), of Ultralife Corporation, a Delaware corporation (“Ultralife”), in exchange for $16.00 per Share, payable in cash, without interest and subject to reduction for any applicable withholding taxes, upon the terms and subject to the conditions set forth in the offer to purchase, dated October 28, 2026 (the “Offer to Purchase”), a copy of which is attached as Exhibit (a)(1)(A), and in the related letter of transmittal (the “Letter of Transmittal”), a copy of which is attached as Exhibit (a)(1)(B), which, as each may be amended or supplemented from time to time, collectively constitute the “Offer.” The Offer will expire at 5:00 p.m., New York City time, on December 3, 2026, unless the Offer is extended or earlier terminated in accordance with the terms of the Merger Agreement. Open the document at this passage
Nov 12
Earnings call
Ultralife enterprise value set at approximately $320 million

EnerSys reported $950 million net sales and, excluding tariff refunds, $154 million adjusted operating earnings and $3.26 adjusted diluted EPS; it agreed to acquire Ultralife at an enterprise value of approximately $320 million.

5 source passages
Good morning, everyone. Thank you for joining us today to discuss EnerSys second quarter 2027 results. Net sales came in at $950 million, roughly flat versus the prior year our adjusted operating earnings, excluding tariff-free funds, were $154 million in the quarter, up 15% versus the prior year Adjusted diluted EPS, excluding the tariff refund, was $3.26 per share, a 23% increase over prior year. we have agreed to acquire Ultralife for an enterprise value of approximately $320 million, funded with cash on hand Open the document at this passage
Nov 12
Current report 8-K Events of Nov 11
Diluted EPS rises to $2.42; dividend declared

EnerSys reported second-quarter fiscal 2027 net sales of $949.9 million, diluted EPS of $2.42 and adjusted diluted EPS of $3.22. Its board declared a $0.2875 per-share dividend payable December 31, 2026, to holders of record December 18, 2026.

Financial results, Other events Read from the first part of this long document
4 source passages
Net sales for the second quarter of fiscal 2027 were $949.9 million, a decrease of 0.1% from the prior year second quarter net sales of $951.3 million and below the range of the second quarter of fiscal 2027 guidance of $955 million to $995 million. Net earnings attributable to EnerSys stockholders (“Net earnings”) for the second quarter of fiscal 2027 were $89.6 million, or $2.42 per diluted share, which included an unfavorable highlighted net of tax impact of $29.3 million, or $0.80 per diluted share, from highlighted items described in further detail in the tables shown below, reconciling non-GAAP adjusted financial measures to reported amounts. Excluding these highlighted items, adjusted Net earnings per diluted share for the second quarter of fiscal 2027, on a non-GAAP basis, were $3.22, compared to the guidance of $3.15 to $3.25 per diluted share for the second quarter given by the Company on August 12, 2026. EnerSys (NYSE: ENS), a global leader in stored energy solutions for industrial, infrastructure, and defense applications announced today that its Board of Directors has declared a quarterly cash dividend of $0.2875 per share of common stock payable on December 31, 2026, to holders of record as of December 18, 2026. Open the document at this passage
Nov 12
Quarterly report 10-Q FY2027 Q2, ended Oct 4
Ultralife acquisition proposed as gross profit rises

EnerSys proposes to acquire Ultralife for $16.00 per share in cash, valuing it at approximately $320 million and expecting closure in the first quarter of calendar year 2027. Six-month fiscal 2027 gross profit rose $67.4 million, or 12.7%.

Revenue $949.9M ▼ 0.1% Net income $89.57M ▲ 30.9% Diluted EPS $2.42 ▲ 34.4%
Read from the MD&A section
3 source passages
Under the terms of the Merger Agreement, the Company, through a subsidiary, will commence a tender offer to acquire all of the outstanding shares of Ultralife common stock at a price of $16.00 per share in cash at closing, representing a total enterprise value of approximately $320 million. The transaction is subject to customary closing conditions, including the tender of at least a majority of the outstanding shares of Ultralife’s common stock and receipt of applicable regulatory approvals, and is expected to close in the first quarter of calendar year 2027. Gross profit increased $7.2 million or 2.6% in the second quarter and increased $67.4 million or 12.7% in the six months of fiscal 2027 compared to the comparable periods of fiscal 2026. Open the document at this passage
Oct 28
Tender offer SC TO-T
Tender offer

EnerSys, via EnerSys Mergersub Inc., is offering $16.00 per share in cash for all outstanding Ultralife Corporation shares, with the offer expiring December 3, 2026 unless extended. It has no financing condition and would make Ultralife a wholly owned subsidiary.

Read from the first part of this long document
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$3.79B
Trailing 12 months
Net income (TTM)
$373.70M
Trailing 12 months
Revenue growth YoY
-0.1%
Year over year
Operating margin
13.6%
Trailing 12 months
P / E (TTM)
14.4
Trailing earnings · reciprocal yield 7.0%
FCF yield
12.8%
TTM · current market cap
Return on invested capital
17.9%
Trailing 12 months
Net cash
−$517.50M
Latest balance sheet
Dividend yield
0.8%
Trailing 12 months
Shares change YoY
-2.7%
Year over year · fewer shares
Price change (1Y)
+3.9%
Trailing year
Short interest
7.2%
Latest settlement · 5.3 days to cover
View all 125 metrics

AI Brief

Q2 FY27 earnings call · Nov 12, 2026
Q2 FY27

TL;DR. EnerSys delivered gross-margin and EPS growth, strong PPS and NIS performance, higher orders and backlog, and increased fiscal-year-to-date free cash flow, while the proposed Ultralife acquisition is expected to add synergies and EPS accretion. Sales missed guidance, IMS remained pressured by material-handling softness and unfavorable mix, and Q3 faces margin headwinds from mix, tough comparisons, and freight and commodity inflation.

Bullish
  • + Gross margin expanded to 29.9% (25.2% ex-IRC 45X), while diluted EPS rose 34% to $2.42. new
  • + PPS revenue rose 21%, with adjusted operating earnings up 43% and adjusted operating margin up 340 basis points. new
  • + NIS revenue rose 3%, while adjusted operating earnings increased 38% and adjusted operating margin expanded 290 basis points. new
  • + Orders rose 21% year over year, backlog increased 36%, and book-to-bill reached 1.09. new
  • + Fiscal-year-to-date free cash flow increased to $348.0 million from $165.1 million. new
  • + The proposed Ultralife acquisition is expected to generate approximately $15 million to $20 million of annual run-rate cost synergies and adjusted EPS accretion within 18 months of closing. new
Bearish
  • − Second-quarter net sales were below guidance and decreased 0.1% year over year. new
  • − IMS revenue fell 8%, adjusted operating earnings declined 13%, and adjusted operating margin contracted 60 basis points. new
  • − Material handling orders declined by a lower single-digit percentage year over year amid an uncertain recovery. new
  • − Third-quarter IMS margins are expected to face pressure as transportation grows faster than higher-margin material handling. new
  • − PPS and NIS face tough prior-year margin comparisons due to project timing and quarterly fluctuations. new
  • − Freight and commodity inflation increased and may take a quarter to recover through pricing. new

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −25%
below
Price vs 50-day avg −17%
below
RSI (14) 33
neutral
MACD trend Negative
52-week position 9%
near low
Momentum
relative strength
Very Weak
1-month return −15%
trailing
6-month return −41%
trailing
YTD return −3%
this year
Relative strength −42%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $172 › 200d $191 — 200d above 50d
Institutional flow Distributing
496 of 560 funds reported for Sep 30 · net -105.0K sh shares · +62 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
7.16% of shares out · ▼ -8.1% MoM · 5.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
560 holders — near 3-yr high, broad support
Squeeze score 71
high risk · 0–100
Fundamentals
Strong
Revenue growth +16%
Y/Y
Gross margin 508%
contracting
EPS growth −14%
Y/Y
Free cash flow $467.5M
Valuation P/E 14.4
below peers
Buyback $1.0B
authorized
Balance sheet $648.9M
net debt
Quant / Vol
risk profile
Very High
Volatility 44%
annualized · 1-yr
Max drawdown −41%
past year
ATR 5.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 4 of last 8
Latest guidance · from the Earnings Call filed Nov 12, 2026
within 18 months of closing
Annual run rate cost synergies $15M – $20M
fiscal year 2027
Full-year tax rate on an as-adjusted basis before the benefit of Non-GAAP 21.5% – 23.5%
full-year tax rate ... for fiscal year 2027
Tax rate Non-GAAP 21.5% – 23.5%
fiscal year 27
Capex $70M
third quarter of fiscal 2027
Net sales $935M – $975M
prior qtr $949.9M midpoint +0.5% QoQ
Adjusted diluted EPS Non-GAAP $3.05 – $3.15
Previous outlook earlier release · from the Earnings Call filed Aug 13, 2026

Still-open targets the latest release did not restate under the same label.

Net sales · second quarter of fiscal 2027 $955M – $995M
45X benefits to cost of sales · second quarter of fiscal 2027 $42M – $47M
Adjusted diluted EPS excluding 45X · second quarter of fiscal 2027 $1.95 – $2.05
Effective tax rate (as-adjusted, before 45X benefit) · full year fiscal 2027 21.5% – 23.5%
Guided vs delivered · last 8 settled
Net sales second quarter of fiscal 2027
guided $955M – $995M
$949.9M Miss −2.6%
Net sales first quarter of fiscal 2027
guided $915M – $955M
$935.64M In line
Net sales fourth quarter of fiscal 2026
guided $960M – $1B
$987.94M In line
Net sales third quarter of fiscal 2026
guided $920M – $960M
$919.13M Miss −2.2%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 2 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−25% Bearish
Price vs 50-day avg
−17% Bearish
RSI (14)
33 Neutral
MACD trend
Negative Bearish
52-week position
9% Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $172 › 200d $191 — 200d above 50d
Institutional flow Distributing
496 of 560 funds reported for Sep 30 · net -105.0K sh shares · +62 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
7.16% of shares out · ▼ -8.1% MoM · 5.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
560 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $133 Now $143 · 9% Range high $243
vs 200-day avg -25% vs 50-day avg -17%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted Diluted EPS (Non-GAAP)(1) non-GAAP $6.88 Six months of fiscal 2027 —
adjusted diluted EPS ex IRC 45X non-GAAP $2.02 Second quarter of fiscal 2027 —
Adjusted EBITDA (non-GAAP) per credit agreement non-GAAP 697.6M Last twelve months ended 10/4/2026 —
Adjusted Gross Profit non-GAAP 598.9M Six months ended 10/4/2026 —
cash from operating activities $372.8M Six months of fiscal 2027 —
EBITDA (non-GAAP) non-GAAP 608.6M Last twelve months ended 10/4/2026 —
Gross Margin (GM) 29.9% Second quarter of fiscal 2027 —
net debt $554.9M As of October 4, 2026 —
Non-GAAP adjusted Net earnings excluding (ex) IRC 45X benefit non-GAAP 74.5M Quarter ended 10/4/2026 —
Non-GAAP adjusted Net Earnings without IRC 45X non-GAAP 165M Six months ended 10/4/2026 —
quarterly dividend payment $10.3M second quarter —
Total net debt non-GAAP 554.9M Last twelve months ended 10/4/2026 —
Total Non-GAAP adjustments non-GAAP 36.2M Quarter ended 10/4/2026 —
Adjusted Operating Margin non-GAAP 19.1% Quarter ended July 5, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Electrical Equipment & Parts — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ENS
EnerSys
this stock
$5.09B -2.6% +15.8% 14.4 7.2%
CYATY
Contemporary Amperex Technology Co., Limited
$216.19B — — — 0.0%
ABLZF
Abb Ltd
$149.44B +7.9% +9.5% — 0.2%
VRT
Vertiv Holdings Co
$77.81B +24.7% +27.7% 37.8 2.9%
BE
Bloom Energy Corp
$56.76B +121.0% +37.3% 117.1 6.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
577
% held
103.0%
Reported
496 of 560
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
530
View
Short & Settlement
Short Interest Falling
Shares short
2.5M
Days to cover
5.3d
Change
-223.3K sh
View
Short Volume
Short vol %
71%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
8
Value
$1.4K
As of
Oct 9, 2026
View
Off-Exchange
Off-exchange %
40.0%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Buy
Member
Greg Gianforte
Amount
$15.0K–$50.0K
Traded
Mar 2, 2020
View
Financials
Financials
Revenue (FY)
$216.1M
Net income (FY)
$293.6M
EPS diluted
$7.70
View
Buybacks
Authorized
$1.0B
View
Filings
SEC Filings
Latest
SC TO-T/A
Filed
Nov 13, 2026
This year
24

EnerSys amended its tender offer statement for Ultralife, offering $16.00 per share in cash. The offer expires at 5:00 p.m., New York City time, on December 3, 2026, unless extended or earlier terminated under the Merger Agreement.

View
Proposed Sales
Value
$1.0M
Shares
6.7K
Filed
Dec 10, 2025
View
Earnings & Events
Webcasts
Last webcast
Nov 12, 2026
View
Investor Relations
Latest news
EnerSys Announces Dividend of $0.…
Published
Nov 11, 2026
View

Performance

5D 20D 120D MTD YTD
ENS -2.7% -15.2% -41.2% -10.6% -2.6%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY -5.3% -14.1% -41.7% -10.4% -13.2%

Capital returns

Latest dividend
$0.288 / share · ex Sep 18, 2026
Declared · upcoming
$0.2875 / share · ex Dec 18, 2026
Raised 9.5%
Paid (TTM)
$1.077 / share · 4 payouts
Dividend yield (TTM, derived)
0.75%
Full dividend history
Buyback program · as of Aug 6, 2025
Authorized
$1.00B
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1289308 CUSIP 29275Y102 13F (30d) 457 filings 405 filers Visit website Investor relations